CN1966047A - Chinese medicinal formulation for treating prostate hyperplasia - Google Patents
Chinese medicinal formulation for treating prostate hyperplasia Download PDFInfo
- Publication number
- CN1966047A CN1966047A CN 200610114543 CN200610114543A CN1966047A CN 1966047 A CN1966047 A CN 1966047A CN 200610114543 CN200610114543 CN 200610114543 CN 200610114543 A CN200610114543 A CN 200610114543A CN 1966047 A CN1966047 A CN 1966047A
- Authority
- CN
- China
- Prior art keywords
- parts
- herba
- semen
- vinegar
- stir
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000002307 prostate Anatomy 0.000 title abstract description 5
- 206010020718 hyperplasia Diseases 0.000 title abstract description 3
- 238000009472 formulation Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 238000002360 preparation method Methods 0.000 claims abstract description 18
- 210000000582 semen Anatomy 0.000 claims description 42
- 239000003814 drug Substances 0.000 claims description 40
- 239000000052 vinegar Substances 0.000 claims description 22
- 235000021419 vinegar Nutrition 0.000 claims description 22
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 claims description 21
- 208000004403 Prostatic Hyperplasia Diseases 0.000 claims description 16
- 239000002994 raw material Substances 0.000 claims description 13
- 241000222640 Polyporus Species 0.000 claims description 11
- 239000012266 salt solution Substances 0.000 claims description 11
- 239000000843 powder Substances 0.000 claims description 9
- 239000002775 capsule Substances 0.000 claims description 7
- 239000008187 granular material Substances 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 6
- 239000003826 tablet Substances 0.000 claims description 6
- 239000006196 drop Substances 0.000 claims description 5
- -1 electuary Substances 0.000 claims description 5
- 229940023488 pill Drugs 0.000 claims description 5
- 239000006187 pill Substances 0.000 claims description 5
- 239000002552 dosage form Substances 0.000 claims description 4
- 229940046011 buccal tablet Drugs 0.000 claims description 3
- 239000006189 buccal tablet Substances 0.000 claims description 3
- 239000000243 solution Substances 0.000 claims description 3
- 241001629511 Litchi Species 0.000 claims 3
- 244000183278 Nephelium litchi Species 0.000 abstract description 7
- 244000307697 Agrimonia eupatoria Species 0.000 abstract 1
- 241000202726 Bupleurum Species 0.000 abstract 1
- 241000050051 Chelone glabra Species 0.000 abstract 1
- 244000077995 Coix lacryma jobi Species 0.000 abstract 1
- 240000009138 Curcuma zedoaria Species 0.000 abstract 1
- 235000003405 Curcuma zedoaria Nutrition 0.000 abstract 1
- 240000007171 Imperata cylindrica Species 0.000 abstract 1
- 235000003805 Musa ABB Group Nutrition 0.000 abstract 1
- 240000008790 Musa x paradisiaca Species 0.000 abstract 1
- 235000015742 Nephelium litchi Nutrition 0.000 abstract 1
- 241000157511 Oldenlandia Species 0.000 abstract 1
- 235000015266 Plantago major Nutrition 0.000 abstract 1
- 244000171085 Polyporus umbellatus Species 0.000 abstract 1
- 235000004837 Polyporus umbellatus Nutrition 0.000 abstract 1
- 244000197580 Poria cocos Species 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 244000178320 Vaccaria pyramidata Species 0.000 abstract 1
- 235000010587 Vaccaria pyramidata Nutrition 0.000 abstract 1
- 235000000125 common agrimony Nutrition 0.000 abstract 1
- 239000001812 curcuma zedoaria berg. rosc. Substances 0.000 abstract 1
- 210000003462 vein Anatomy 0.000 abstract 1
- 235000019509 white turmeric Nutrition 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 23
- 230000000694 effects Effects 0.000 description 13
- 239000000796 flavoring agent Substances 0.000 description 13
- 235000019634 flavors Nutrition 0.000 description 13
- 210000004185 liver Anatomy 0.000 description 12
- 239000008280 blood Substances 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 9
- 206010030113 Oedema Diseases 0.000 description 8
- 208000002193 Pain Diseases 0.000 description 8
- 208000004880 Polyuria Diseases 0.000 description 7
- 210000003734 kidney Anatomy 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 230000035619 diuresis Effects 0.000 description 6
- 210000004072 lung Anatomy 0.000 description 6
- 230000001737 promoting effect Effects 0.000 description 6
- 210000000952 spleen Anatomy 0.000 description 6
- 235000009508 confectionery Nutrition 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 206010007247 Carbuncle Diseases 0.000 description 4
- 206010012735 Diarrhoea Diseases 0.000 description 4
- 206010017553 Furuncle Diseases 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 206010013990 dysuria Diseases 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 208000014674 injury Diseases 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 201000004792 malaria Diseases 0.000 description 4
- 230000027939 micturition Effects 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 239000003440 toxic substance Substances 0.000 description 4
- 230000002485 urinary effect Effects 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 208000001848 dysentery Diseases 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 206010025482 malaise Diseases 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 230000008736 traumatic injury Effects 0.000 description 3
- 238000005303 weighing Methods 0.000 description 3
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 201000000736 Amenorrhea Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 241000721047 Danaus plexippus Species 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 206010062575 Muscle contracture Diseases 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 230000001142 anti-diarrhea Effects 0.000 description 2
- 230000002605 anti-dotal effect Effects 0.000 description 2
- 208000002894 beriberi Diseases 0.000 description 2
- 235000019658 bitter taste Nutrition 0.000 description 2
- 206010006451 bronchitis Diseases 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 208000006111 contracture Diseases 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 208000004396 mastitis Diseases 0.000 description 2
- 230000002175 menstrual effect Effects 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 206010044008 tonsillitis Diseases 0.000 description 2
- 210000003932 urinary bladder Anatomy 0.000 description 2
- 239000002435 venom Substances 0.000 description 2
- 231100000611 venom Toxicity 0.000 description 2
- 210000001048 venom Anatomy 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 208000037157 Azotemia Diseases 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 241001597008 Nomeidae Species 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 240000005373 Panax quinquefolius Species 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 1
- 206010046814 Uterine prolapse Diseases 0.000 description 1
- 241000934136 Verruca Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 208000000260 Warts Diseases 0.000 description 1
- 208000031975 Yang Deficiency Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000037006 agalactosis Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- NKWPZUCBCARRDP-UHFFFAOYSA-L calcium bicarbonate Chemical compound [Ca+2].OC([O-])=O.OC([O-])=O NKWPZUCBCARRDP-UHFFFAOYSA-L 0.000 description 1
- 229910000020 calcium bicarbonate Inorganic materials 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 210000003756 cervix mucus Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 201000001352 cholecystitis Diseases 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 229940121657 clinical drug Drugs 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000002662 enteric coated tablet Substances 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 239000007941 film coated tablet Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 206010019847 hepatosplenomegaly Diseases 0.000 description 1
- 229940056582 human hair preparation Drugs 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000005184 men's health Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 235000002378 plant sterols Nutrition 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- 238000009666 routine test Methods 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 201000005113 shigellosis Diseases 0.000 description 1
- 150000003376 silicon Chemical class 0.000 description 1
- 201000010153 skin papilloma Diseases 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000007940 sugar coated tablet Substances 0.000 description 1
- 238000009495 sugar coating Methods 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 208000006379 syphilis Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 208000009852 uremia Diseases 0.000 description 1
- 210000001635 urinary tract Anatomy 0.000 description 1
- 201000002327 urinary tract obstruction Diseases 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 206010046901 vaginal discharge Diseases 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a Chinese medicinal preparation for treating prostate gland hyperplasia which is prepared from poria cocos, cogongrass rhizome, polyporus umbellatus, plantain seeds, zedoary, lychee seed, oldenlandia, barbat skullcap, hairy vein agrimony, Bupleurum root, coix seed and seed of cowherb.
Description
Technical field
The present invention relates to a kind of Chinese medicine preparation for the treatment of prostatic hyperplasia, is that a kind of prostatic hyperplasia for the treatment of is the Chinese patent medicine of raw material with the Chinese herbal medicine.Belong to the field of Chinese medicines.
Background technology
Hyperplasia of prostate claims benign prostatic hyperplasia again, also claims prostate hyperplasia, is a kind of commonly encountered diseases that influences elderly men health that increases because of prostate is obvious.Be to cause old people's urine retention, the reason that urinary system infection and uremia are common.Hyperplasia of prostate is a clinical characters with carrying out property frequent micturition, dysuria, and early symptom is obscure, and along with lower urinary tract obstruction increases the weight of, symptom is obvious gradually.It is reported that domestic sickness rate accounts for 35% of male more than 40 years old, in fact may be higher.The sickness rate of external hyperplasia of prostate is apparently higher than domestic, the sick rational prostatic hyperplasia of the Crinis Carbonisatus of 50～60 years old elderly men nearly 50%, and at the elderly men more than 80 years old, its sickness rate can be up to 80%～90%.Hyperplasia of prostate belongs to the category of Chinese medicine " difficulty in urination ", " smart infirmity ".It is unobstructed that the traditional Chinese medical science thinks that the normal person urinates, and depend on the normal of qiactivity of triple energizer, and qiactivity of triple energizer mainly relies on lung spleen kidney three dirty keeping.So it is primary disease is except that having the substantial connection with kidney, also usually relevant with lung, spleen, three warmers.The clinical type Coryza Treated by Syndrome Differentiation such as damp invasion of lower energizer, deficiency of QI in middle-JIAO, kidney yang deficiency, damage of kidney-YIN, the resistance of the urinary tract stasis of blood, lung-heat heap soil or fertilizer over and around the roots Sheng, stagnation of QI due to depression of the liver that often are divided into.At present, the western medical treatment hyperplasia of prostate mainly adopts operative treatment.Side effect is big, and recurrence brings huge misery to the patient easily.
Summary of the invention
The present invention develops in conjunction with the latest modern technological scientific achievement on the basis of traditional tcm syndrome differentiation and treatment.The purpose of this invention is to provide a kind of Chinese medicine preparation for the treatment of prostatic hyperplasia, have determined curative effect, safe ready, have no side effect, cheap characteristics.
The present invention is made by the following weight proportion raw material:
1.5～6 parts of 0.1～2 part of Herba Hedyotidis Diffusaes of 2.5～10 parts of Semen Litchis of Rhizoma Smilacis Glabrae
1.5～6 parts of 1.5～6 parts of stir-baked SEMEN PLANTAGINIS with salt solution of 0.1～2 portion of Herba Scutellariae Barbatae of Herba Solani Lyrati
1.5～6 parts of 1.5～6 parts of Semen Coicis of 1.5～6 parts of Radix Bupleuri (processed with vinegar) of Herba Agrimoniae
0.1～2 part of 1.5～6 parts of Semen Vaccariae (parched) of 1.5～6 portions of Polyporus of stir-baked RHIIZOMA CURCUMAE with vinegar
The weight proportion of each raw material of optimization formula of the present invention is:
2.5～3.5 parts of 0.5～1.5 part of Herba Hedyotidis Diffusaes of 3～7 parts of Semen Litchis of Rhizoma Smilacis Glabrae
2.5～3.5 parts of 2.5～3.5 parts of stir-baked SEMEN PLANTAGINIS with salt solution of 0.5～1.5 portion of Herba Scutellariae Barbatae of Herba Solani Lyrati
2.5～3.5 parts of 2.5～3.5 parts of Semen Coicis of 2.5～3.5 parts of Radix Bupleuri (processed with vinegar) of Herba Agrimoniae
0.5～1.5 part of 2.5～3.5 parts of Semen Vaccariae (parched) of 2.5～3.5 portions of Polyporus of stir-baked RHIIZOMA CURCUMAE with vinegar
The weight proportion of each raw material of optimum formula of the present invention is:
3 parts of 1 part of Herba Hedyotidis Diffusaes of 5 parts of Semen Litchis of Rhizoma Smilacis Glabrae
3 parts of 3 parts of stir-baked SEMEN PLANTAGINIS with salt solution of 1 portion of Herba Scutellariae Barbatae of Herba Solani Lyrati
3 parts of 3 parts of Semen Coicis of 3 parts of Radix Bupleuri (processed with vinegar) of Herba Agrimoniae
1 part of 3 parts of Semen Vaccariae (parched) of 3 portions of Polyporus of stir-baked RHIIZOMA CURCUMAE with vinegar
Drug action mechanism among the present invention is as follows:
The Rhizoma Smilacis Glabrae nature and flavor are sweet, light, flat.Return liver, stomach warp.Has heat-clearing and toxic substances removing, wind-damp dispelling, bone and muscle strengthening, sharp joint, anticancer effect.Can treat damp and hot sore, eczema, rheumatic ostalgia, limbs contracture, Fructus Myricae rubrae malignant boil, urinary system infection, syphilis, stranguria with turbid discharge, stranguria leucorrhea, dyspepsia, diarrhoea, beriberi, furuncle, carbuncle, scrofula etc.(Ji Yubin chief editor " Chinese medicine medicine for preventing pharmacology and application " Heilungkiang science tech publishing house 1999 version the 87th page).
Herba Solani Lyrati nature and flavor sweetness and bitterness, cold.Have heat clearing away, dampness removing dispels the wind, the antidotal effect.Can treat malaria, jaundice, edema, gonorrhea, rheumatic arthritis, erysipelas, furuncle etc.(" Chinese medicine voluminous dictionary " the 701st page.)
The Polyporus nature and flavor are sweet, light, and are flat.Return kidney, urinary bladder channel.Effect with promoting diuresis to eliminate damp pathogen.Can treat dysuria, edema is had loose bowels, stranguria with turbid discharge, leukorrhagia etc.(the 259th page of Chemical Industry Press of Pharmacopoeia of the People's Republic of China version in 2000 is compiled by Chinese Pharmacopoeia Commission).
The stir-baked SEMEN PLANTAGINIS with salt solution nature and flavor are sweet, be slightly cold.Return liver, kidney, lung, small intestinal, urinary bladder channel.Has clearing away heat and promoting diuresis, eliminating dampness by diuresis antidiarrheal, liver heat removing and eyesight improving, the effect of removing heat from the lung and dissipating phlegm.Can treat the cough due to lung-heat, urinary system infection, calculus, gastritis edema, dysuria, enteritis, bacillary dysentery, acute icterohepatitisshock, bronchitis, acute eye conjunctivitis, stranguria with turbid discharge, leukorrhagia, hematuria, edema, hematodiarrhoea is had loose bowels, epistaxis, conjunctival congestion and swelling pain, sore throat tonsillitis, cough, skin ulcer etc.(Ji Yubin chief editor " Chinese medicine medicine for preventing pharmacology and application " Heilungkiang science tech publishing house 1999 version the 291st page).
Stir-baked RHIIZOMA CURCUMAE with vinegar nature and flavor hardship, suffering, temperature.Return liver, spleen channel.Have the circulation of qi promoting removing blood stasis with potent drugs, the removing food stagnancy pain relieving is changed poly-eliminating mass, the effect of antiearly pregnancy.Can treat that trusted subordinate's distending pain, lump in the abdomen, dyspepsia do not disappear, hepatosplenomegaly, abdominal pain due to blood stasis, amenorrhea due to stagnation of blood, cervical erosion, traumatic injury have a pain etc.(Ji Yubin chief editor " Chinese medicine medicine for preventing pharmacology and application " Heilungkiang science tech publishing house 1999 version the 995th page).
The Semen Litchi sweet-puckery flavor, temperature.Return liver, kidney channel.Have warming middle-JIAO, regulate the flow of vital energy, the analgesic effect.Can treat gastric abscess, colicky, women's pricking caused by the stagnation of QI and blood etc.(" Chinese medicine voluminous dictionary " the 1616th page.)
Herba Hedyotidis Diffusae nature and flavor hardship, sweet, cold.GUIXIN, liver, stomach three warps.Has heat-clearing and toxic substances removing, inducing diuresis to remove edema, promoting blood circulation and stopping pain, anti-inflammation, anticancer effect.Can treat cough due to lung-heat, tonsillitis, pharyngolaryngitis, carbuncle furuncle, traumatic injury, urinary system infection, bronchitis, venom etc.(Ji Yubin chief editor " Chinese medicine medicine for preventing pharmacology and application " Heilungkiang science tech publishing house 1999 version the 476th page).
Herba Scutellariae Barbatae nature and flavor suffering, hardship, cold.Return lung, liver, kidney channel.Has heat-clearing and toxic substances removing, blood stasis dispelling diuretic effect.Can treat furuncle swelling toxin, laryngopharynx swelling and pain, venom falls and pounces on the pain of injury, edema, jaundice etc.(the 89th page of Chemical Industry Press of Pharmacopoeia of the People's Republic of China version in 2000 is compiled by Chinese Pharmacopoeia Commission).
Herba Agrimoniae nature and flavor hardship, puckery, flat.GUIXIN, Liver Channel.Has astringing to arrest bleeding, preventing the attack (or recurrence) of malaria, dysentery relieving, antidotal effect.Can treat hemoptysis, spit blood, metrostaxis, malaria, dysentery is taken off the power impairment caused by overstrain, carbuncle sore tumefacting virus, pudendal pruritus leukorrhagia etc.(the 76th page of Chemical Industry Press of Pharmacopoeia of the People's Republic of China version in 2000 is compiled by Chinese Pharmacopoeia Commission).
Radix Bupleuri (processed with vinegar) nature and flavor hardship, be slightly cold.Return liver, gallbladder meridian.Effect with reconciling superficies and interior, soothing the liver, yang invigorating.Can treat alternate attack of chill and fever, fullness in the chest and hypochondriac pain, deafness, headache and dizziness, malaria, dysentery proctoptosis, menoxenia, uterine prolapse, flu, upper respiratory tract infection, hepatitis, cholecystitis etc.(Ji Yubin chief editor " Chinese medicine medicine for preventing pharmacology and application " Heilungkiang science tech publishing house 1999 version the 1004th page).
The Semen Coicis nature and flavor are sweet, light, cool.Return spleen, stomach, lung meridian.Has the spleen invigorating eliminating dampness by diuresis, eliminating impediment antidiarrheal, the effect of clearing away heat and discharging pus.Can treat edema, beriberi, dysuria, arthralgia chiefly caused by damp pathogen contracture, diarrhea due to hypofunction of the spleen, lung abscess, intestinal carbuncle; Verruca plana etc.(the 309th page of Chemical Industry Press of Pharmacopoeia of the People's Republic of China version in 2000 is compiled by Chinese Pharmacopoeia Commission).
Semen Vaccariae (parched) nature and flavor hardship, flat.Return liver, stomach warp.Have promoting blood circulation to restore menstrual flow, stimulating milk secretion repercussive effect.Can treat that agalactia, amenorrhea, dysmenorrhea, difficult labour, stranguria with blood, blood band, black vaginal discharge, mastitis, acute mastitis are swollen and ache, incised wound is hemorrhage, lump in the abdomen, traumatic injury, alluvial, dribbling urination, arthralgia etc.(Ji Yubin chief editor " Chinese medicine medicine for preventing pharmacology and application " Heilungkiang science tech publishing house 1999 version the 238th page).
The present invention follows the principles of formulating prescriptions of the traditional Chinese medical science " monarch ", is monarch drug with Rhizoma Smilacis Glabrae, Herba Solani Lyrati, Polyporus and Herba Hedyotidis Diffusae; With stir-baked RHIIZOMA CURCUMAE with vinegar, Herba Scutellariae Barbatae, Herba Agrimoniae, Radix Bupleuri (processed with vinegar), Semen Coicis and Semen Vaccariae (parched) is ministerial drug; With stir-baked SEMEN PLANTAGINIS with salt solution and Semen Litchi is adjuvant.All medicines have the effect of heat-clearing and toxic substances removing, inducing diuresis to remove edema, promoting blood circulation to restore menstrual flow mutually and altogether, the treatment prostatic hyperplasia, and determined curative effect has no side effect, and taking convenience is cheap.
Chinese medicine preparation of the present invention, can add the medicine acceptable carrier when being prepared into medicament, described medicine acceptable carrier can be: starch, sucrose, lactose, mannitol, silicon derivative, cellulose family and derivant thereof, alginate, gelatin, polyvinylpyrrolidone, glycerol, soil temperature 80, agar, calcium carbonate, calcium bicarbonate, surfactant, Polyethylene Glycol, cyclodextrin, beta-schardinger dextrin-, phospholipid material, Kaolin, Pulvis Talci, calcium stearate, magnesium stearate etc.
Chinese medicine preparation of the present invention can be any pharmaceutically useful dosage form, and these dosage forms comprise: tablet, sugar coated tablet, film coated tablet, enteric coated tablet, capsule, hard capsule, soft capsule, oral liquid, buccal tablet granule, electuary, pill, powder, unguentum, sublimed preparation, suspensoid, powder, solution, injection, suppository, ointment, plaster, cream, spray, drop, patch.Preparation of the present invention, peroral dosage form preferably, as: tablet, capsule, oral liquid, buccal tablet, granule, electuary, pill, powder, suspensoid, powder, solution, drop, drop pill.Preferred Chinese medicine preparation is capsule, tablet, granule.
Clinical drug of the present invention uses the result to show that following advantage is arranged:
1, the Chinese herbal medicine each component selected for use of the present invention meets the regulation of The Drug Administration Law of People's Republic of China, utilizes the comprehensive function treatment and the prevention of prostatic hyperplasia of the Chinese medicine of respectively distinguishing the flavor of, and is nontoxic to human body.Show that through animal acute toxicity experiment the animal of being tested does not see any toxic reaction, its main organs does not have tangible change yet, and safety of medicine is reliable.
2, the present invention need not decoct, no bitterness sense, rich in proteins in the medicine, glucose, glucuronic acid, volatile oil, pectin, fructose, organic acid, lecithin, vitamin, aminoacid, also contain various trace elements such as Saponin, plant sterol and calcium, be beneficial to absorption of human body, health invigorating, and taking convenience.
3, the present invention not only can effectively treat prostatic hyperplasia, and the prevention of prostatic hyperplasia is also had good effect, has improved patient's life quality greatly, and higher healing rehabilitation efficacy is arranged.
Prostatic hyperplasia (difficulty in urination) curative effect determinate standard: (the 222nd page of chief editor's " traditional Chinese medical science disease diagnosis and treatment standard and prescription are selected for use " People's Health Publisher's calendar year 2001 version such as Dai Shen).
1, cure: it is unobstructed to urinate, and symptom and sign disappear.
2, take a turn for the better: symptom and sign are improved.
3, do not heal: the symptom no change.
Further specify the therapeutic effect of medicine of the present invention below by the clinical practice example to the treatment prostatic hyperplasia.
As follows through clinical test results; Treatment prostatic hyperplasia patient 39 examples, the age is 50～72 years old.Take embodiment 1 capsule, each 2-10 grain, every day three to four times, eliminating cold for resuscitation water send down, and take half an hour ante cibum.Two months is a course of treatment, take continuously three the course of treatment observe the curative effect.Cure 20 examples and account for 51.2%, 15 examples that take a turn for the better account for 38.46%, and invalid 4 examples account for 10.25%, and total effective rate reaches more than 89%.After three course of therapy, patient's prostate obviously dwindles, and urinates unobstructed or reaches criterion of cure.And patient does not have any untoward reaction, and three big routine tests and hepatic and renal function detect no abnormal.
The specific embodiment
Embodiment 1 capsule takes by weighing raw material by following weight:
3 parts of 1 part of Herba Hedyotidis Diffusaes of 5 parts of Semen Litchis of Rhizoma Smilacis Glabrae
3 parts of 3 parts of stir-baked SEMEN PLANTAGINIS with salt solution of 1 portion of Herba Scutellariae Barbatae of Herba Solani Lyrati
3 parts of 3 parts of Semen Coicis of 3 parts of Radix Bupleuri (processed with vinegar) of Herba Agrimoniae
1 part of 3 parts of Semen Vaccariae (parched) of 3 portions of Polyporus of stir-baked RHIIZOMA CURCUMAE with vinegar
Preparation method is to get above-mentioned raw materials to decoct with water twice, 1.5～2 hours for the first time, and 0.5～1 hour for the second time, merge decocting liquid twice, filter, filtrate is concentrated into 80 degree～85 when spending, the clear paste of relative density 1.08～1.10, adding ethanol makes clear paste contain the alcohol amount to reach 70%, left standstill 24 hours, reclaim ethanol, when spending, 50 degree～55 are concentrated into the clear paste of relative density 1.30～1.32, drying is ground into fine powder, incapsulates.Adorn 0.3 gram for every, usually half an hour ante cibum oral, eliminating cold for resuscitation water send down, one time 2～10, three to four times on the one, two months is a course of treatment.
Embodiment 2 tablets take by weighing raw material by following weight:
6 parts of 2 parts of Herba Hedyotidis Diffusaes of 10 parts of Semen Litchis of Rhizoma Smilacis Glabrae
6 parts of 6 parts of stir-baked SEMEN PLANTAGINIS with salt solution of 2 portions of Herba Scutellariae Barbataes of Herba Solani Lyrati
6 parts of 6 parts of Semen Coicis of 6 parts of Radix Bupleuri (processed with vinegar) of Herba Agrimoniae
2 parts of 6 parts of Semen Vaccariae (parched)s of 6 portions of Polyporus of stir-baked RHIIZOMA CURCUMAE with vinegar
Preparation method is to get above-mentioned raw materials to decoct with water twice, 1.5～2 hours for the first time, 0.5～1 hour for the second time, merge decocting liquid twice, filter, filtrate is concentrated into 80 degree～85 when spending, the clear paste of relative density 1.08～1.10, adding ethanol makes clear paste contain the alcohol amount to reach 70%, left standstill 24 hours, reclaim ethanol, when spending, 50 degree～55 are concentrated into the clear paste of relative density 1.30～1.32, drying is ground into fine powder, adds appropriate amount of starch, alcohol granulation, after the drying, add an amount of magnesium stearate, tabletting, sugar coating are promptly.Usually half an hour ante cibum oral, eliminating cold for resuscitation water send down, one time 2～10, three to four times on the one, two months is a course of treatment.
Embodiment 3 granules take by weighing raw material by following weight:
1.5 parts of 0.5 part of Herba Hedyotidis Diffusaes of 2.5 parts of Semen Litchis of Rhizoma Smilacis Glabrae
1.5 parts of 1.5 parts of stir-baked SEMEN PLANTAGINIS with salt solution of 0.5 portion of Herba Scutellariae Barbatae of Herba Solani Lyrati
1.5 parts of 1.5 parts of Semen Coicis of 1.5 parts of Radix Bupleuri (processed with vinegar) of Herba Agrimoniae
0.5 part of 1.5 parts of Semen Vaccariae (parched) of 1.5 portions of Polyporus of stir-baked RHIIZOMA CURCUMAE with vinegar
Preparation method is to get above-mentioned raw materials to decoct with water twice, 1.5～2 hours for the first time, and 0.5～1 hour for the second time, merge decocting liquid twice, filter, filtrate is concentrated into 80 degree～85 when spending, the clear paste of relative density 1.08～1.10 adds ethanol and makes clear paste contain the alcohol amount to reach 70%, left standstill 24 hours, reclaim ethanol, when 50 degree～55 are spent, be concentrated into the clear paste of relative density 1.30～1.32, drying, be ground into fine powder, add an amount of sucrose and soluble starch, alcohol granulation, the pack of dry back is promptly.Usually half an hour ante cibum warm boiled water, one time 1～3 bag, three to four times on the one, two months is a course of treatment.
Claims (6)
1, a kind of Chinese medicine preparation for the treatment of prostatic hyperplasia.It is characterized in that it is made by the following weight proportion raw material:
1.5～6 parts of 0.1～2 part of Herba Hedyotidis Diffusaes of 2.5～10 parts of Semen Litchis of Rhizoma Smilacis Glabrae
1.5～6 parts of 1.5～6 parts of stir-baked SEMEN PLANTAGINIS with salt solution of 0.1～2 portion of Herba Scutellariae Barbatae of Herba Solani Lyrati
1.5～6 parts of 1.5～6 parts of Semen Coicis of 1.5～6 parts of Radix Bupleuri (processed with vinegar) of Herba Agrimoniae
0.1～2 part of 1.5～6 parts of Semen Vaccariae (parched) of 1.5～6 portions of Polyporus of stir-baked RHIIZOMA CURCUMAE with vinegar
2, a kind of Chinese medicine preparation for the treatment of prostatic hyperplasia according to claim 1, wherein the weight proportion of each raw material is:
2.5～3.5 parts of 0.5～1.5 part of Herba Hedyotidis Diffusaes of 3～7 parts of Semen Litchis of Rhizoma Smilacis Glabrae
2.5～3.5 parts of 2.5～3.5 parts of stir-baked SEMEN PLANTAGINIS with salt solution of 0.5～1.5 portion of Herba Scutellariae Barbatae of Herba Solani Lyrati
2.5～3.5 parts of 2.5～3.5 parts of Semen Coicis of 2.5～3.5 parts of Radix Bupleuri (processed with vinegar) of Herba Agrimoniae
0.5～1.5 part of 2.5～3.5 parts of Semen Vaccariae (parched) of 2.5～3.5 portions of Polyporus of stir-baked RHIIZOMA CURCUMAE with vinegar
3, a kind of Chinese medicine preparation for the treatment of prostatic hyperplasia according to claim 1, wherein the weight proportion of each raw material is:
3 parts of 1 part of Herba Hedyotidis Diffusaes of 5 parts of Semen Litchis of Rhizoma Smilacis Glabrae
3 parts of 3 parts of stir-baked SEMEN PLANTAGINIS with salt solution of 1 portion of Herba Scutellariae Barbatae of Herba Solani Lyrati
3 parts of 3 parts of Semen Coicis of 3 parts of Radix Bupleuri (processed with vinegar) of Herba Agrimoniae
1 part of 3 parts of Semen Vaccariae (parched) of 3 portions of Polyporus of stir-baked RHIIZOMA CURCUMAE with vinegar
4, the Chinese medicine preparation of claim 1-3 is to be fit to medicinal various dosage forms.
5, the Chinese medicine preparation of claim 4 is tablet, capsule, oral liquid, buccal tablet, granule, electuary, pill, powder, suspensoid, powder, solution, drop, drop pill.
6, the Chinese medicine preparation of claim 4 is capsule, tablet, granule.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006101145431A CN100450537C (en) | 2006-11-15 | 2006-11-15 | Chinese medicinal formulation for treating prostate hyperplasia |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006101145431A CN100450537C (en) | 2006-11-15 | 2006-11-15 | Chinese medicinal formulation for treating prostate hyperplasia |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1966047A true CN1966047A (en) | 2007-05-23 |
| CN100450537C CN100450537C (en) | 2009-01-14 |
Family
ID=38075140
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2006101145431A Expired - Fee Related CN100450537C (en) | 2006-11-15 | 2006-11-15 | Chinese medicinal formulation for treating prostate hyperplasia |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100450537C (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103536848A (en) * | 2013-09-29 | 2014-01-29 | 刘新霞 | Traditional Chinese medicine decoction used for treating chronic prostatitis |
| KR20220120748A (en) * | 2021-02-22 | 2022-08-31 | 충남대학교산학협력단 | Composition for preventing, improving or treating prostate disease comprising extract of Agrimonia pilosa Ledebour as effective component |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1468622A (en) * | 2002-07-16 | 2004-01-21 | 卢国频 | Recipe and production process of medicine granule for treating prostatitis |
| CN1506081A (en) * | 2002-12-09 | 2004-06-23 | 曾泽勋 | Medicine for treating prostatosis |
-
2006
- 2006-11-15 CN CNB2006101145431A patent/CN100450537C/en not_active Expired - Fee Related
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103536848A (en) * | 2013-09-29 | 2014-01-29 | 刘新霞 | Traditional Chinese medicine decoction used for treating chronic prostatitis |
| CN103536848B (en) * | 2013-09-29 | 2015-11-25 | 刘新霞 | The Chinese medicine decoction for the treatment of chronic prostatitis |
| KR20220120748A (en) * | 2021-02-22 | 2022-08-31 | 충남대학교산학협력단 | Composition for preventing, improving or treating prostate disease comprising extract of Agrimonia pilosa Ledebour as effective component |
| KR102536101B1 (en) * | 2021-02-22 | 2023-05-30 | 충남대학교산학협력단 | Composition for preventing, improving or treating prostate disease comprising extract of Agrimonia pilosa Ledebour as effective component |
Also Published As
| Publication number | Publication date |
|---|---|
| CN100450537C (en) | 2009-01-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1839941A (en) | Chinese prepared medicine for treating bone pain | |
| CN1943745A (en) | A Chinese traditional medicinal preparation for treatment of urticaria | |
| CN101028376A (en) | Chinese medicinal preparation for treating habitual abortion | |
| CN101032593A (en) | Acne-treating Chinese medicine preparation | |
| CN1943699A (en) | A Chinese traditional medicinal preparation for treatment of eczema | |
| CN101028419A (en) | Chinese-medicinal preparation for treating nongonococcal urethritis | |
| CN100415278C (en) | A Chinese traditional medicinal preparation for treatment of eczema | |
| CN102579807B (en) | Chinese medicine composition for treating dental ulcer | |
| CN1857449A (en) | Chinese medicine for treating puerperal hypogalactia | |
| CN101028490A (en) | Chinese medicine for treating acne | |
| CN100450537C (en) | Chinese medicinal formulation for treating prostate hyperplasia | |
| CN100431578C (en) | Preparation of Chinese traditional medicine for treating hyperplasia of prostate | |
| CN1857450A (en) | Chinese medicine prepn for treating dysmenorrhea | |
| CN100431592C (en) | Chinese medicinal formulation for treating hyperplasia of prostate | |
| CN100381141C (en) | Chinese medicine for treating prostatic hyperplasia | |
| CN100415288C (en) | A Chinese traditional medicinal preparation for treatment of psoriasis | |
| CN101028492A (en) | Chinese preparation for treating hysteromyoma | |
| CN101028421B (en) | Chinese medicine for treating chronic kidney failure | |
| CN101028451A (en) | Chinese medicine for treating tic douloureux | |
| CN1931262A (en) | Common cold treating Chinese medicine prepn | |
| CN1943700A (en) | A Chinese traditional medicinal preparation for treatment of eczema | |
| CN101028491A (en) | Chinese-medicinal preparation for treating ribbon bleb | |
| CN1939497A (en) | Chinese-medicinal preparation for treating uterine-tube obstructive infertilitas | |
| CN101028352A (en) | Chinese-medicinal preparation for treating ischiodynia | |
| CN101066428A (en) | Medicine for treating sterility of aspermia and its prepn process |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: BEIJING WAN SHOU TONG PHARMACEUTICAL TECHNOLOGY C Free format text: FORMER OWNER: WANG XINSUO Effective date: 20080822 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20080822 Address after: Room 230 (Park), No. 19 West Fourth Ring Road South, Beijing, Fengtai District, China: 100072 Applicant after: Beijing Wanshoutong Pharmaceutical Technology Corp. Address before: Beijing Beijing Yixin Pharmaceutical Research Institute, postcode 100078 Applicant before: Wang Xinsuo |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20090114 Termination date: 20101115 |